Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections

BACKGROUND: We conducted this study to describe the clinical characteristics, microbiology, and outcomes of patients treated with ceftazidime-avibactam (CZA) for a range of multidrug-resistant Gram-negative (MDR-GN) infections. METHODS: This is a multicenter, retrospective cohort study conducted at...

Descripción completa

Detalles Bibliográficos
Autores principales: Jorgensen, Sarah C J, Trinh, Trang D, Zasowski, Evan J, Lagnf, Abdalhamid M, Bhatia, Sahil, Melvin, Sarah M, Steed, Molly E, Simon, Samuel P, Estrada, Sandra J, Morrisette, Taylor, Claeys, Kimberly C, Rosenberg, Joshua R, Davis, Susan L, Rybak, Michael J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934163/
https://www.ncbi.nlm.nih.gov/pubmed/31890725
http://dx.doi.org/10.1093/ofid/ofz522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934163/
https://www.ncbi.nlm.nih.gov/pubmed/31890725
http://dx.doi.org/10.1093/ofid/ofz522

Ejemplares similares